Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) CEO Sells 8,279 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Matthew B. Klein sold 8,279 shares...
Your Source for Insightful Trends and Discussions.
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Matthew B. Klein sold 8,279 shares...